Merck
CN
  • Increased degradation in rat liver induced by antilipolytic agents: a model for studying autophagy and protein degradation in liver?

Increased degradation in rat liver induced by antilipolytic agents: a model for studying autophagy and protein degradation in liver?

Experimental and molecular pathology (1987-02-01)
E Bergamini, V De Tata, T L Cubeddu, P Masiello, M Pollera
摘要

A dramatic increase in the plasma glucagon/insulin ratio can be induced by treating fasted rats with antilipolytic drugs (e.g., with 3,5-dimethylpyrazole, 12 mg/kg body wt). These hormone changes are the physiologically appropriate response to a rapid decrease in free fatty acids and glucose plasma levels. Under this experimental condition, many vacuolated lysosomes can be observed at the electron microscopic level as early as 30 min and autophagic vacuoles are detectable in the liver cells 1 hr after the administration of the drug. By 1 hr and 45 min, vacuoles often contain recognizable peroxisomes. At the biochemical level, liver proteolysis in vitro is increased significantly. Very interestingly, changes in peroxisomal (but not mitochondrial or reticulum or cytosolic) enzyme activities are detected that are preventable by the administration of glutamine (i.e., of an inhibitor of proteolysis in vivo) but not by an isocaloric amount of glycine or alanine. It is concluded that the administration of antilipolytic agents to fasted animals may provide a convenient (i.e., an inexpensive, highly reproducible and timable) physiologic model to study hormone-induced autophagy in liver cells.

材料
货号
品牌
产品描述

Sigma-Aldrich
3,5-二甲基吡唑, 99%
Sigma-Aldrich
3,5-二甲基吡唑, produced by Wacker Chemie AG, Burghausen, Germany, ≥99.0% (GC)